The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

Lei Zhang, Yidong Li, Qianchao Wang, +7

Molecular Cancer

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression

Zhenzhen Pan, K. Wang, Xiniao Wang, +7

Molecular Cancer

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

Zhenduo Shi, Lin Hao, Xiaoxiao Han, +16

Molecular Cancer

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells

Zhuo‐Xun Wu, Qiu‐Xu Teng, Chao‐Yun Cai, +7

Biochemical Pharmacology

Tumor BiologyMedicinePharmacologyImmune Checkpoint InhibitorAnti-cancer Agent +4

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Weiguo Feng, Meng Zhang, Zhuo‐Xun Wu, +7

Frontiers in Oncology

Tumor BiologyOncologyHealth SciencesAbcb1 Atpase ActivityMedicine +10

Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells

Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu, +4

MedComm

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

Zhuo‐Xun Wu, Yuqi Yang, Qiu‐Xu Teng, +7

Cancers

A C-met InhibitorChemoprevention StrategyPharmacotherapyAbcg2-mediated Drug ResistanceDrug Resistance +14

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

Yuqi Yang, Ning Ji, Qiu‐Xu Teng, +7

Frontiers in Oncology

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

Jingqiu Wang, Dong‐Hua Yang, Yuqi Yang, +7

International Journal of Molecular Sciences

Abcb1 TransporterPharmacotherapyAntimicrobial ChemotherapyCancer BiologyTumor Biology +16

Modulating the function of ABCB1: <i>in vitro</i> and <i>in vivo</i> characterization of sitravatinib, a tyrosine kinase inhibitor

Yuqi Yang, Ning Ji, Chao‐Yun Cai, +7

Cancer Communications